Daclatasvir
Daclatasvir market is segmented by region (country), players, by Type and by Application. Players ... Read More
Global and United States Regorafenib Market Report & Forecast 2023-2028
1 Study Coverage
1.1 Regorafenib Product Introduction
1.2 Global Regorafenib Outlook 2017 VS 2022 VS 2028
1.2.1 Global Regorafenib Sales in US$ Million for the Year 2017-2028
1.2.2 Global Regorafenib Sales in Volume for the Year 2017-2028
1.3 United States Regorafenib Outlook 2017 VS 2022 VS 2028
1.3.1 United States Regorafenib Sales in US$ Million for the Year 2017-2028
1.3.2 United States Regorafenib Sales in Volume for the Year 2017-2028
1.4 Regorafenib Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Regorafenib in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Regorafenib Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Regorafenib Market Dynamics
1.5.1 Regorafenib Industry Trends
1.5.2 Regorafenib Market Drivers
1.5.3 Regorafenib Market Challenges
1.5.4 Regorafenib Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Regorafenib Market Segment by Type
2.1.1 Bottled Packaging
2.1.2 Film Coated Packaging
2.2 Global Regorafenib Market Size by Type
2.2.1 Global Regorafenib Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Regorafenib Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Regorafenib Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Regorafenib Market Size by Type
2.3.1 United States Regorafenib Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Regorafenib Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Regorafenib Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Regorafenib Market Segment by Application
3.1.1 Metastatic Colorectal Cancer
3.1.2 Advanced Gastrointestinal Stromal Tumours
3.1.3 Advanced Hepatocellular Carcinoma
3.1.4 Other
3.2 Global Regorafenib Market Size by Application
3.2.1 Global Regorafenib Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Regorafenib Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Regorafenib Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Regorafenib Market Size by Application
3.3.1 United States Regorafenib Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Regorafenib Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Regorafenib Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Regorafenib Competitor Landscape by Company
4.1 Global Regorafenib Market Size by Company
4.1.1 Top Global Regorafenib Manufacturers Ranked by Revenue (2021)
4.1.2 Global Regorafenib Revenue by Manufacturer (2017-2022)
4.1.3 Global Regorafenib Sales by Manufacturer (2017-2022)
4.1.4 Global Regorafenib Price by Manufacturer (2017-2022)
4.2 Global Regorafenib Concentration Ratio (CR)
4.2.1 Regorafenib Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Regorafenib in 2021
4.2.3 Global Regorafenib Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Regorafenib Manufacturing Base Distribution, Product Type
4.3.1 Global Regorafenib Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Regorafenib Product Type
4.3.3 Date of International Manufacturers Enter into Regorafenib Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Regorafenib Market Size by Company
4.5.1 Top Regorafenib Players in United States, Ranked by Revenue (2021)
4.5.2 United States Regorafenib Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Regorafenib Sales by Players (2020, 2021 & 2022)
5 Global Regorafenib Market Size by Region
5.1 Global Regorafenib Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Regorafenib Market Size in Volume by Region (2017-2028)
5.2.1 Global Regorafenib Sales in Volume by Region: 2017-2022
5.2.2 Global Regorafenib Sales in Volume Forecast by Region (2023-2028)
5.3 Global Regorafenib Market Size in Value by Region (2017-2028)
5.3.1 Global Regorafenib Sales in Value by Region: 2017-2022
5.3.2 Global Regorafenib Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Regorafenib Market Size YoY Growth 2017-2028
6.1.2 North America Regorafenib Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Regorafenib Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Regorafenib Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Regorafenib Market Size YoY Growth 2017-2028
6.3.2 Europe Regorafenib Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Regorafenib Market Size YoY Growth 2017-2028
6.4.2 Latin America Regorafenib Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Regorafenib Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Regorafenib Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Bayer Pharmaceuticals
7.1.1 Bayer Pharmaceuticals Corporation Information
7.1.2 Bayer Pharmaceuticals Description and Business Overview
7.1.3 Bayer Pharmaceuticals Regorafenib Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Bayer Pharmaceuticals Regorafenib Products Offered
7.1.5 Bayer Pharmaceuticals Recent Development
7.2 Beacon Pharmaceuticals
7.2.1 Beacon Pharmaceuticals Corporation Information
7.2.2 Beacon Pharmaceuticals Description and Business Overview
7.2.3 Beacon Pharmaceuticals Regorafenib Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Beacon Pharmaceuticals Regorafenib Products Offered
7.2.5 Beacon Pharmaceuticals Recent Development
7.3 Drug International
7.3.1 Drug International Corporation Information
7.3.2 Drug International Description and Business Overview
7.3.3 Drug International Regorafenib Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Drug International Regorafenib Products Offered
7.3.5 Drug International Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Regorafenib Industry Chain Analysis
8.2 Regorafenib Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Regorafenib Distributors
8.3 Regorafenib Production Mode & Process
8.4 Regorafenib Sales and Marketing
8.4.1 Regorafenib Sales Channels
8.4.2 Regorafenib Distributors
8.5 Regorafenib Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Regorafenib CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Regorafenib Market Trends
Table 3. Regorafenib Market Drivers
Table 4. Regorafenib Market Challenges
Table 5. Regorafenib Market Restraints
Table 6. Global Regorafenib Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Regorafenib Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Regorafenib Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Regorafenib Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Regorafenib Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Regorafenib Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Regorafenib Revenue Share by Manufacturer, 2017-2022
Table 13. Global Regorafenib Sales by Manufacturer, (K Pcs), 2017-2022
Table 14. Global Regorafenib Sales Share by Manufacturer, 2017-2022
Table 15. Global Regorafenib Price by Manufacturer (2017-2022) & (USD/Pcs)
Table 16. Global Regorafenib Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Regorafenib by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Regorafenib as of 2021)
Table 18. Top Players of Regorafenib in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Regorafenib Product Type
Table 20. Date of International Manufacturers Enter into Regorafenib Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Regorafenib Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Regorafenib Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Regorafenib Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Regorafenib Sales by Players, (K Pcs), 2020, 2021 & 2022
Table 26. United States Regorafenib Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Regorafenib Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Regorafenib Sales in Volume by Region (2017-2022) & (K Pcs)
Table 29. Global Regorafenib Sales in Volume Forecast by Region (2023-2028) & (K Pcs)
Table 30. Global Regorafenib Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Regorafenib Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Regorafenib Sales in Volume by Country (2017-2028) & (K Pcs)
Table 33. North America Regorafenib Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Regorafenib Sales in Volume by Region (2017-2028) & (K Pcs)
Table 35. Asia Pacific Regorafenib Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Regorafenib Sales in Volume by Country (2017-2028) & (K Pcs)
Table 37. Europe Regorafenib Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Regorafenib Sales in Volume by Country (2017-2028) & (K Pcs)
Table 39. Latin Americaa Regorafenib Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Regorafenib Sales in Volume by Country (2017-2028) & (K Pcs)
Table 41. Middle East and Africa Regorafenib Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Bayer Pharmaceuticals Corporation Information
Table 43. Bayer Pharmaceuticals Description and Business Overview
Table 44. Bayer Pharmaceuticals Regorafenib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 45. Bayer Pharmaceuticals Regorafenib Product
Table 46. Bayer Pharmaceuticals Recent Development
Table 47. Beacon Pharmaceuticals Corporation Information
Table 48. Beacon Pharmaceuticals Description and Business Overview
Table 49. Beacon Pharmaceuticals Regorafenib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 50. Beacon Pharmaceuticals Product
Table 51. Beacon Pharmaceuticals Recent Development
Table 52. Drug International Corporation Information
Table 53. Drug International Description and Business Overview
Table 54. Drug International Regorafenib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 55. Drug International Product
Table 56. Drug International Recent Development
Table 57. Key Raw Materials Lists
Table 58. Raw Materials Key Suppliers Lists
Table 59. Regorafenib Customers List
Table 60. Regorafenib Distributors List
Table 61. Research Programs/Design for This Report
Table 62. Key Data Information from Secondary Sources
Table 63. Key Data Information from Primary Sources
List of Figures
Figure 1. Regorafenib Product Picture
Figure 2. Global Regorafenib Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Regorafenib Market Size 2017-2028 (US$ Million)
Figure 4. Global Regorafenib Sales 2017-2028 (K Pcs)
Figure 5. United States Regorafenib Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Regorafenib Market Size 2017-2028 (US$ Million)
Figure 7. United States Regorafenib Sales 2017-2028 (K Pcs)
Figure 8. United States Regorafenib Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Regorafenib Market Share in Global, in Volume (K Pcs) 2017-2028
Figure 10. Regorafenib Report Years Considered
Figure 11. Product Picture of Bottled Packaging
Figure 12. Product Picture of Film Coated Packaging
Figure 13. Global Regorafenib Market Share by Type in 2022 & 2028
Figure 14. Global Regorafenib Sales in Value by Type (2017-2028) & (US$ Million)
Figure 15. Global Regorafenib Sales Market Share in Value by Type (2017-2028)
Figure 16. Global Regorafenib Sales by Type (2017-2028) & (K Pcs)
Figure 17. Global Regorafenib Sales Market Share in Volume by Type (2017-2028)
Figure 18. Global Regorafenib Price by Type (2017-2028) & (USD/Pcs)
Figure 19. United States Regorafenib Market Share by Type in 2022 & 2028
Figure 20. United States Regorafenib Sales in Value by Type (2017-2028) & (US$ Million)
Figure 21. United States Regorafenib Sales Market Share in Value by Type (2017-2028)
Figure 22. United States Regorafenib Sales by Type (2017-2028) & (K Pcs)
Figure 23. United States Regorafenib Sales Market Share in Volume by Type (2017-2028)
Figure 24. United States Regorafenib Price by Type (2017-2028) & (USD/Pcs)
Figure 25. Product Picture of Metastatic Colorectal Cancer
Figure 26. Product Picture of Advanced Gastrointestinal Stromal Tumours
Figure 27. Product Picture of Advanced Hepatocellular Carcinoma
Figure 28. Product Picture of Other
Figure 29. Global Regorafenib Market Share by Application in 2022 & 2028
Figure 30. Global Regorafenib Sales in Value by Application (2017-2028) & (US$ Million)
Figure 31. Global Regorafenib Sales Market Share in Value by Application (2017-2028)
Figure 32. Global Regorafenib Sales by Application (2017-2028) & (K Pcs)
Figure 33. Global Regorafenib Sales Market Share in Volume by Application (2017-2028)
Figure 34. Global Regorafenib Price by Application (2017-2028) & (USD/Pcs)
Figure 35. United States Regorafenib Market Share by Application in 2022 & 2028
Figure 36. United States Regorafenib Sales in Value by Application (2017-2028) & (US$ Million)
Figure 37. United States Regorafenib Sales Market Share in Value by Application (2017-2028)
Figure 38. United States Regorafenib Sales by Application (2017-2028) & (K Pcs)
Figure 39. United States Regorafenib Sales Market Share in Volume by Application (2017-2028)
Figure 40. United States Regorafenib Price by Application (2017-2028) & (USD/Pcs)
Figure 41. North America Regorafenib Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 42. North America Regorafenib Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 43. U.S. Regorafenib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 44. Canada Regorafenib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 45. Europe Regorafenib Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 46. Europe Regorafenib Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 47. Germany Regorafenib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 48. France Regorafenib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. U.K. Regorafenib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. Italy Regorafenib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. Russia Regorafenib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 52. Asia-Pacific Regorafenib Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 53. Asia-Pacific Regorafenib Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 54. China Regorafenib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 55. Japan Regorafenib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. South Korea Regorafenib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. India Regorafenib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. Australia Regorafenib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Taiwan Regorafenib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Indonesia Regorafenib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Thailand Regorafenib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Malaysia Regorafenib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Philippines Regorafenib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 64. Latin America Regorafenib Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 65. Latin America Regorafenib Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 66. Mexico Regorafenib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Brazil Regorafenib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 68. Argentina Regorafenib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 69. Middle East & Africa Regorafenib Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 70. Middle East & Africa Regorafenib Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 71. Turkey Regorafenib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 72. Saudi Arabia Regorafenib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 73. U.A.E Regorafenib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 74. Regorafenib Value Chain
Figure 75. Regorafenib Production Process
Figure 76. Channels of Distribution
Figure 77. Distributors Profiles
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Bayer Pharmaceuticals Beacon Pharmaceuticals Drug International